MENU
GHRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GH Research (GHRS) Ownership - Who owns GH Research?
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Profile
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
612.84M
P/E Ratio
N/A
Total Cash
149.32M
Projected Growth
N/A
Total Debt
624K
Revenue
N/A
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash/Share
2.41
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GHRS
Capitalization
613M
P/E Ratio
N/A
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash
149M
Total Cash/Share
2.41
Total Debt
624K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
179M
P/B Ratio
3.42
Cash Flow
N/A
Earnings
-0.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.3M
Current Ratio
17.23
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-38.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-18.80
Shares Held By Institutions
208M
Shares Outstanding - Current
62M
Total Liabilities
9.32M
Total Volume MTD
N/A
Value
N/A
Gain YTD
40.857
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com